Floatz logo

Unfractionated Heparin

Childhood Acute Lymphoblastic Leukemia

University of Texas Southwestern Medical CenterUNKNOWNPhase 4 / ApprovedDormant
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
81/ 100

Competitive context

65 Active assets in the Childhood Acute Lymphoblastic Leukemia cohort.

View all 50

Same molecule, other indications

Unfractionated Heparin is also rated in:

venous thromboembolismDormant
B
Indicative · Phase 4
57 / 100
View asset →
myocardial infarctionDormant
B
Indicative · Phase 4
57 / 100
View asset →
vertebral artery dissectionDormant
B
Indicative · Phase 3
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →